论文部分内容阅读
作者通过一随机、双盲、安慰剂对照试验,研究了霍乱减毒活菌苗CVD103-HgR株的临床可接受性、免疫原性以及血型与杀弧菌抗体的关系.
In a randomized, double-blind, placebo-controlled trial, the authors investigated the clinical acceptability, immunogenicity, and the relationship between blood group and Vibrio cholera antibody against live attenuated cholera CVD103-HgR strain.